Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypofractionated Radiotherapy Before or After Breast Surgery for Non-Metastatic Breast Cancer
NCT06635980Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- May 2025
- Primary completion
- Oct 2031
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer (2 arms), sponsored by Mayo Clinic. Primary endpoint: Incidence of grade 3 or higher radiation treatment (RT) related adverse events at 2 years. Started May 2025; status: recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06635980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06635980.